Alphabet's fourth-quarter 2024 results are likely to reflect strength in Generative AI, search and cloud amid litigation ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration approved the pill from Vertex ...
On Feb. 24, from west to east, you can see Mercury, Saturn, Neptune, Venus, Uranus, Jupiter and Mars, all spanning 117.5°, ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
As part of Vertex’s ongoing commitment to patients, the company has established patient support programs to help ensure that qualified patients can access JOURNAVX. For more information visit ...
Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...
While America retains a gold standard for airline safety, there are stresses on the US air travel system that have ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVXâ„¢ (suzetrigine), an oral, non-opioid, highly selective ...
A U.S. Air Force jet with migrants bound at their wrists and ankles departed Texas for Guatemala on Thursday, carrying 80 ...